BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma

By Lee Seung-Tae   Jiang Yun-Fang   Park Keon-Uk   Woo Alison F   Neelapu Sattva S  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 113-122

Informa Healthcare

Access to resources Recommend Favorite

⁹⁰Yttrium–ibritumomab tiuxetan: a novel treatment for non-Hodgkin’s lymphoma

By Blum Kristie A   Bartlett Nancy L  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1323-1331

Informa Healthcare

Access to resources Recommend Favorite

DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt’s lymphoma cells

By Feng Minhua   Huang Bo   Du Zunguo   Xu Xiaoping   Chen Zi  

Molecular Biology Reports, Vol. 38, Iss. 3, 2011-03 ,pp. : 1915-1920

Springer Publishing Company

Access to resources Recommend Favorite

Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients

By Asfour Inas   Shazly Sherin   Fayek Manal   Hegab Hany   Raouf Soha   Moussa Mohamed  

Biological Trace Element Research, Vol. 110, Iss. 1, 2006-04 ,pp. : 19-32

Humana Press, Inc

Access to resources Recommend Favorite

LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death—possible role of dephosphorylation of Akt

By Nakagawa T.   Yasuda T.   Hoshikawa H.   Shimizu M.   Kakinuma T.   Chen M.   Masaki T.   Nakamura T.   Sawamura T.  

Biochemical and Biophysical Research Communications, Vol. 299, Iss. 1, 2002-11 ,pp. : 91-97

Elsevier

Access to resources Recommend Favorite